Neurogene (NASDAQ:NGNE) Earns Buy Rating from Analysts at HC Wainwright
HC Wainwright assumed coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research note released on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $45.00 price target on the stock. HC Wainwright also issued estimates for Neurogene’s Q4 2023 earnings at ($1.66) EPS, FY2023 earnings at ($7.82) EPS, Q1 […]
More Stories
Uquid Coin (UQC) Tops 1-Day Trading Volume of $384,803.21
Uquid Coin (UQC) traded 2.1% higher against the U.S. dollar during the one day period ending at 12:00 PM ET...
Uquid Coin (UQC) Tops 1-Day Trading Volume of $384,803.21
Uquid Coin (UQC) traded 2.1% higher against the U.S. dollar during the one day period ending at 12:00 PM ET...
Amp Achieves Self Reported Market Capitalization of $291.94 Million (AMP)
Amp (AMP) traded up 1.4% against the dollar during the one day period ending at 12:00 PM ET on December...
Amp Achieves Self Reported Market Capitalization of $291.94 Million (AMP)
Amp (AMP) traded up 1.4% against the dollar during the one day period ending at 12:00 PM ET on December...
Blast 24 Hour Trading Volume Reaches $14.77 Million (BLAST)
Blast (BLAST) traded up 2.5% against the US dollar during the 24 hour period ending at 12:00 PM E.T. on...
Blast 24 Hour Trading Volume Reaches $14.77 Million (BLAST)
Blast (BLAST) traded up 2.5% against the US dollar during the 24 hour period ending at 12:00 PM E.T. on...